bf/NASDAQ:CDTX_icon.jpeg

NASDAQ:CDTX

Cidara Therapeutics, Inc.

  • Stock

USD

Last Close

12.95

30/08 20:00

Market Cap

51.64M

Beta: 1.34

Volume Today

40.58K

Avg: 3.19M

PE Ratio

−1.95

PFCF: −2.35

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
asset turnover
0.30
-
0.20
34.14%
0.66
229.54%
1.35
105.25%
cash per share
0.06
-
1.80
2,875.48%
15.37
755.83%
8.55
44.37%
5.13
39.97%
2.88
43.84%
2.01
30.15%
0.86
57.08%
1.19
37.38%
0.47
60.53%
company equity multiplier
-0.14
-
1.15
902.54%
1.06
8.28%
1.21
14.61%
1.32
9.06%
1.34
1.12%
1.82
36.28%
5.64
209.32%
3.49
38.08%
-16.39
569.37%
-8.16
50.18%
days of inventory outstanding
days of payables outstanding
days of sales outstanding
96.79
-
338.02
249.24%
39.44
88.33%
33.12
16.02%
dividend yield
ebit per revenue
-1.99
-
-5.95
198.46%
-0.85
85.68%
-0.46
45.77%
ebt per ebit
1.24
-
1.02
17.62%
1.00
2.64%
0.99
0.19%
1.00
0.58%
0.93
6.76%
0.98
5.61%
1.00
1.91%
1.01
0.14%
0.99
1.14%
effective tax rate
-0.14
-
0.01
110.05%
0.02
6.13%
0.01
21.25%
-0.07
704.37%
0.02
133.88%
-0.00
114.83%
-0.03
834.57%
-0.01
72.87%
enterprise value multiple
-46.53
-
-21.91
52.91%
-1.94
91.14%
-1.15
40.58%
-0.96
16.65%
0.06
105.95%
-1.58
2,856.38%
-0.77
51.13%
-0.22
71.11%
-0.72
223.86%
fixed asset turnover
10.15
-
9.97
1.73%
19.49
95.47%
45.05
131.11%
free cash flow per share
-0.34
-
-0.69
100.48%
-2.73
298.97%
-2.77
1.39%
-2.87
3.49%
-2.20
23.37%
-0.95
56.60%
-1.31
37.67%
-0.48
63.33%
-0.41
15.06%
gross profit margin
1
-
1
0%
1
0%
1
0%
interest coverage
-269.27
-
-178.73
33.63%
7.96K
4,553.71%
-100.61
101.26%
-188.80
87.65%
274.23
245.25%
-199.32
172.68%
-155.59
21.94%
inventory turnover
long term debt to capitalization
17.45
-
0.10
-
0.11
7.67%
0.02
-
0.06
-
-0.77
-
net income per ebt
1
-
1
0%
1
0%
1
0%
1
0%
1
0%
0.98
2.45%
1.00
2.88%
1.03
3.02%
1.01
2.39%
net profit margin
-1.92
-
-6.00
212.93%
-0.89
85.23%
-0.46
47.67%
operating cash flow per share
-0.34
-
-0.61
77.65%
-2.62
330.83%
-2.74
4.90%
-2.85
3.89%
-2.19
23.14%
-0.95
56.52%
-1.31
37.37%
-0.48
63.26%
-0.41
15.27%
operating profit margin
-1.99
-
-5.95
198.46%
-0.85
85.68%
-0.46
45.77%
payables turnover
pretax profit margin
-1.96
-
-5.98
204.16%
-0.86
85.66%
-0.46
46.39%
price fair value
-35.08
-
9.62
127.43%
1.64
82.98%
1.71
4.31%
1.99
16.56%
1.03
48.39%
3.04
195.54%
7.76
155.31%
3.09
60.19%
-18.19
689.18%
receivables turnover
3.77
-
1.08
71.37%
9.26
757.12%
11.02
19.08%
return on assets
-6.69
-
-0.49
92.69%
-0.29
40.07%
-0.45
53.83%
-0.71
56.59%
-0.75
5.80%
-0.58
22.10%
-1.20
106.10%
-0.58
51.33%
-0.63
7.41%
return on capital employed
-12.73
-
-0.55
95.68%
-0.31
43.50%
-0.49
58.99%
-0.83
68.48%
-1.07
28.40%
-1.08
0.69%
-3.29
205.46%
-1.02
68.88%
-1.69
64.87%
return on equity
0.96
-
-0.56
158.63%
-0.31
45.03%
-0.55
76.31%
-0.93
70.77%
-1.00
6.98%
-1.06
6.17%
-6.75
537.52%
-2.04
69.87%
10.26
604.15%
total debt to capitalization
17.45
-
0.10
-
0.14
41.87%
0.14
1.36%
0.24
64.59%
0.43
80.19%
0.19
55.43%
-0.83
536.73%
-1.46
76.32%

All numbers in USD (except ratios and percentages)